De-intensified chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma based on plasma EBV DNA: A phase 2 randomized noninferiority trial.

Hai Qiang Mai,Xiao-Yun Li,Hao Yuan Mo,Guo Ling,Dong Hua Luo,Rui Sun,Li Ting Liu,Shan Shan Guo,Jin Hao Yang,Xue-Song Sun,Qing-Nan Tang,Pan Wang,Ji Bin Li,Qi Yang,Sai Lan Liu,Yu-Jing Liang,Jin Jie Yan,Qiu Yan Chen,Lin Quan Tang

De-intensified chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma based on plasma EBV DNA: A phase 2 randomized noninferiority trial.

2021

Hai Qiang Mai
Xiao-Yun Li
Hao Yuan Mo
Guo Ling
Dong Hua Luo
Rui Sun
Li Ting Liu
Shan Shan Guo
Jin Hao Yang
Xue-Song Sun
Qing-Nan Tang
Pan Wang
Ji Bin Li
Qi Yang
Sai Lan Liu
Yu-Jing Liang
Jin Jie Yan
Qiu Yan Chen
Lin Quan Tang

110Background: The cisplatin-based chemoradiotherapy (CCRT), given at a dose of 100 mg/m2 for 3 cycles during radiotherapy, is the major treatment for locoregionally advanced nasopharyngeal carcino...

Keywords:

Chemoradiotherapy
Nasopharyngeal carcinoma
Medicine
Oncology
Internal medicine
Radiation therapy
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations